With the increasing incidence of respiratory diseases and allergies worldwide, the need for clinical trial expertise in these areas is essential to running a successful clinical study or a full clinical development program. A key quality that distinguishes SCOPE is our ability to provide strong expertise and support to meet enrollment goals on time and within budget. SCOPE can help develop and deliver the enrollment strategy for your respiratory or allergy clinical trial.
In business since 2000, we have conducted over 303 studies with 86,575 patients world-wide. We have offices in 12 countries across Europe with 225 permanent employees. With our partner network, we are operational across all continents and markets wherever clinical trial services are required. SCOPE has significant experience in conducting phase II-IV respiratory clinical trials, ranging from a single protocol to full development programs. In recent years, we have conducted more than 36 studies in the respiratory area for various disease states.
Our patient recruitment, site management and extensive support strategies are uniquely adapted to the specific therapeutic areas and clinical development stages of your product. With our expertise and experience, we can make sure your trial runs as efficiently as possible, meeting all regulatory standards while ensuring consistent quality.
Whether it’s a clinical development trial (phase I-III), post-authorization (phase IV), rescue, adaptive design study, or even a complex device or diagnostic combination design, we have the expertise, know-how, and resources to guide you smoothly through all phases of development while meeting your objectives in a timely and cost-efficient manner.
Our team of clinical project managers, clinical research associates (CRAs), data managers, experienced biostatisticians and medical staff are well-versed in managing and monitoring the procedures associated with objectives and end points used in many respiratory protocols.
We value strong relationships with clinical investigators and key opinion leaders, and our expertise enables us to provide rapid feasibility and consulting services on a wide variety of respiratory protocol concepts and designs. As a result, our pharmaceutical and biotech clients can make decisions quickly and move their development programs forward at a rapid pace.
Our expertise in respiratory development enables us to accomplish recruitment of clinical research projects using the experience of each member of our project team to ensure the successful outcome of your important projects. SCOPE provides a well-established approach for successful respiratory trials.
SCOPE project teams are experts in the design and delivery of site training to ensure protocol-consistent enrollment and efficacy assessments, using electronic data capture systems (EDC, eCOA e.g. ePRO) and innovative study tools including our own project management tool.
Project Team
Device Experience
Our team of Biostatisticians provide advice about study design with reference to randomization & stratification, non-inferiority and adaptive design. Additionally, SCOPE supports post-marketing and pharmacoeconomic assessments.
We support projects focusing on conditions such as hypertension, myocardial infarction, and pulmonary arterial hypertension – all high-impact topics in cardiovascular care and research.
Our experience spans across immune-related areas like allergies and vaccinations – key therapeutic fields with growing relevance.
We help communicate complex topics in metabolic disorders, including type 1 diabetes, where patient education and clarity are crucial.
From Non-Hodgkin lymphoma to various solid tumors – such as bladder, breast, colorectal, or prostate cancer – we bring clarity to oncology and hematology communication.
We develop content for dental indications such as periodontitis, caries prevention, oral mucositis, and temporomandibular disorders – always with precision and sensitivity.
We work on indications like alopecia areata, hypertrophic scars, and psoriasis – conditions that often impact both physical and emotional wellbeing.
Our projects cover topics such as diabetes, hormonal imbalances, and metabolic disorders – essential areas in endocrinology.
From Crohn’s disease and ulcerative colitis to irritable bowel syndrome and reflux – we translate complex GI conditions into clear communication.
We support education and awareness campaigns on hepatitis B and C, liver fibrosis, non-alcoholic fatty liver disease (NAFLD), and cirrhosis – all major topics in liver health.
Conditions like rheumatoid arthritis and polymyalgia rheumatica require nuanced and evidence-based communication – a strength we bring to every campaign.
Whether it’s conjunctivitis or retinopathy – we create accessible content for eye disorders aimed at both professionals and patients.
Rare diseases like idiopathic sudden sensorineural hearing loss demand tailored, precise messaging – we’re here to deliver just that.
We support communication around orthopedic topics such as cartilage defects and osteoarthritis – with a focus on clarity and empathy.
From sudden hearing loss and rhinitis to rare conditions like Schwannomas – we bring ENT topics to life with targeted messaging.
We cover a range of urological topics – from bladder and prostate cancer to bladder pain syndrome and kidney cancer – always with scientific accuracy and approachability.
Our work includes vaccine communication for Hepatitis B, influenza, rabies, and tuberculosis – complex topics made clear and compliant.